Journal Article

At-home blood collection and stabilization in high temperature climates using homeRNA

Haack, Amanda J., Takezawa, Meg G., Kennedy, Dakota S., Lim, Fang Yun, Theberge, Ashleigh B., Stolarczuk, Jennifer E., Brown, Lauren G., Adams, Karen N., Chaussabel, Damien, Thongpang, Sanitta, Garand, Mathieu, Berthier, Erwin

2022

Overview

Expanding whole blood sample collection for transcriptome analysis beyond traditional phlebotomy clinics will open new frontiers for remote immune research and telemedicine. Determining the stability of RNA in blood samples exposed to high ambient temperatures (>30°C) is necessary for deploying home-sampling in settings with elevated temperatures (e.g., studying physiological response to natural disasters that occur in warm locations or in the summer). Recently, we have developed home RNA, a technology that allows for self-blood sampling and RNA stabilization remotely. home RNA consists of a lancet-based blood collection device, the Tasso-SST™ which collects up to 0.5 ml of blood from the upper arm, and a custom-built stabilization transfer tube containing RNA later™ . In this study, we investigated the robustness of our home RNA kit in high temperature settings via two small pilot studies in Doha, Qatar (no. participants = 8), and the Western and South Central USA during the summer of 2021, which included a heatwave of unusually high temperatures in some locations (no. participants = 11). Samples collected from participants in Doha were subjected to rapid external temperature fluctuations from being moved to and from air-conditioned areas and extreme heat environments (up to 41°C external temperature during brief temperature spikes). In the USA pilot study, regions varied in outdoor temperature highs (between 25°C and 43.4°C). All samples that returned a RNA integrity number (RIN) value from the Doha, Qatar group had a RIN ≥7.0, a typical integrity threshold for downstream transcriptomics analysis. RIN values for the Western and South Central USA samples ( n  = 12 samples) ranged from 6.9–8.7 with 9 out of 12 samples reporting RINs ≥7.0. Overall, our pilot data suggest that home RNA can be used in some regions that experience elevated temperatures, opening up new geographical frontiers in disseminated transcriptome analysis for applications critical to telemedicine, global health, and expanded clinical research. Further studies, including our ongoing work in Qatar, USA, and Thailand, will continue to test the robustness of home RNA.

• Publisher: Frontiers Media SA,Frontiers Media S.A
• Subject: Anticoagulants / Biomarkers / Design / Digital Health / Gene expression / global health / High temperature / high temperature sampling / home blood sampling / personalized medicine / Phlebotomy / Pilot projects / Precision medicine / RNA stabilization / Smoke inhalation